Nambo, Riku
Karashima, Shigehiro
Mizoguchi, Ren
Konishi, Seigo
Hashimoto, Atsushi
Aono, Daisuke
Kometani, Mitsuhiro
Furukawa, Kenji
Yoneda, Takashi
Imamura, Kousuke
Nambo, Hidetaka
Article History
Received: 14 October 2023
Accepted: 30 April 2024
First Online: 7 May 2024
Competing interests
: K. Furukawa received lecture fees from Sanofi K.K., Eli Lilly Japan K.K., and Ono Pharmaceutical Co., Ltd. A. The remaining authors declare no conflicts of interest with respect to this research or paper.